tokyo-med-mcm.jp

The Molecular Cell Therapy Research Division is at the forefront of innovative cancer research, focusing on the intricate mechanisms of cancer malignancy and therapeutic applications. This esteemed division specializes in groundbreaking projects, including the elucidation of cancer progression mechanisms through miRNA, the development of liquid biopsies utilizing exosomes, and novel cancer treatments targeting exosomes.

Under the leadership of distinguished researchers, including Professor Takahiro Rakutani, the division has achieved remarkable accolades, being ranked as a global leader in exosome research. Recent findings highlight the anti-inflammatory properties of exosomes derived from lung cells, contributing to ongoing advancements in cancer diagnostics and treatment. Their research has been recognized in prestigious journals, including Communications Biology and Science Advances, showcasing their commitment to enhancing healthcare outcomes.

The division continuously publishes their work, fostering collaboration and knowledge sharing among scientific communities, all while aiming to develop new biomarkers for ovarian cancer diagnosis and prognosis. Engage with their groundbreaking developments through their comprehensive research publications and updates.